Peetz Christopher bought ARQT
July 15, 2026 · Form 4 insider transaction
Peetz Christopher bought 13,010 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,010
Price
$0.00
Total value
N/A
InsiderPeetz Christopher
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 15, 2026
Filing dateJuly 17, 2026
Shares owned after13,010
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.